Chondros Dimitrios 4
4 · HALOZYME THERAPEUTICS INC · Filed Feb 5, 2019
Insider Transaction Report
Form 4
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2019-02-03$16.12/sh−2,503$40,348→ 31,599 total
Footnotes (1)
- [F1]The reported disposition of 2,503 shares represents the shares that were withheld by the issuer as payment for minimum statutory obligations due upon vesting of 6,165 restricted stock award shares.